Additional tumor-related genes were mutated at the level of the PDTC component, also identified in the neighboring ATC and both metastatic lesions (i.e., APC, DROSHA, TP53, TERT, KMT2A, and ASXL1), implying that one or several of these contributed to the dedifferentiation process. This evidence concerns the gene TP53 and neoplasm.